Gene · 2175
Papers3,803
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 3,803
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Breast Cancer Germline Genetic Counseling and Testing for Populations of African Heritage Globally: A Scoping Review on Research, Practice, and Bioethical Considerations. | JCO Glob Oncol | 2023 | 37944088 | PubTator, text mining | PubMed |
| Mutant RB1 enhances therapeutic efficacy of PARPis in lung adenocarcinoma by triggering the cGAS/STING pathway. | JCI Insight | 2023 | 37937640 | PubTator, text mining | PubMed |
| Impact of germline DNA repair gene variants on prognosis and treatment of men with advanced prostate cancer. | Sci Rep | 2023 | 37932350 | PubTator, text mining | PubMed |
| Risk-taking in consumers' online purchases of health supplements and natural products: a grounded theory approach. | J Pharm Policy Pract | 2023 | 37924079 | PubTator, text mining | PubMed |
| Prostaglandin E2 as transduction enhancer affects competitive engraftment of human hematopoietic stem and progenitor cells. | Mol Ther Methods Clin Dev | 2023 | 37920236 | PubTator, text mining | PubMed |
| Whole exome sequencing identifies common mutational landscape of cervix and endometrium small cell neuroendocrine carcinoma. | Front Oncol | 2023 | 37920164 | PubTator, text mining | PubMed |
| Widespread BRCA1/2-independent homologous recombination defects are caused by alterations in RNA-binding proteins. | Cell Rep Med | 2023 | 37909041 | PubTator, text mining | PubMed |
| R-Loops in Genome Instability and Cancer. | Cancers (Basel) | 2023 | 37894353 | PubTator, text mining | PubMed |
| De Novo Metastatic Prostate Cancer: Are We Moving toward a Personalized Treatment? | Cancers (Basel) | 2023 | 37894312 | PubTator, text mining | PubMed |
| Nutritional Status of Children with Newly Diagnosed Food Allergies. | Children (Basel) | 2023 | 37892350 | PubTator, text mining | PubMed |
| Novel, clinically relevant genomic patterns identified by comprehensive genomic profiling in ATRX-deficient IDH-wildtype adult high-grade gliomas. | Sci Rep | 2023 | 37891325 | PubTator, text mining | PubMed |
| DNA damage and repair: underlying mechanisms leading to microcephaly. | Front Cell Dev Biol | 2023 | 37881689 | PubTator, text mining | PubMed |
| Gata2 noncoding genetic variation as a determinant of hematopoietic stem/progenitor cell mobilization efficiency. | Blood Adv | 2023 | 37871305 | PubTator, text mining | PubMed |
| SHaploseek is a sequencing-only, high-resolution method for comprehensive preimplantation genetic testing. | Sci Rep | 2023 | 37865712 | PubTator, text mining | PubMed |
| Identification of a robust DNA methylation signature for Fanconi anemia. | Am J Hum Genet | 2023 | 37865086 | PubTator, text mining | PubMed |
| PRMT5 Inhibitors Regulate DNA Damage Repair Pathways in Cancer Cells and Improve Response to PARP Inhibition and Chemotherapies. | Cancer Res Commun | 2023 | 37861290 | PubTator, text mining | PubMed |
| Similarities and differences in gene expression profiles of BRCA1 methylated and mutated epithelial ovarian cancers. | Front Oncol | 2023 | 37854675 | PubTator, text mining | PubMed |
| Next-generation sequencing in dermatology. | Front Med (Lausanne) | 2023 | 37841001 | PubTator, text mining | PubMed |
| Piezoelectric Drop-on-Demand Inkjet Printing with Ultra-High Droplet Velocity. | Research (Wash D C) | 2023 | 37840768 | PubTator, text mining | PubMed |
| Epigenetic regulation of TP53 is involved in prostate cancer radioresistance and DNA damage response signaling. | Signal Transduct Target Ther | 2023 | 37840069 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2175/papers?page=16